US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

295.76

-35.4700-10.71%

Post-market: 295.760.00000.00%19:55 EDT

Volume:530.48K

Turnover:162.52M

Market Cap:569.19M

PE:- -

High:323.00

Open:322.79

Low:294.70

Close:331.23

52wk High:341.93

52wk Low:68.00

Shares:1.92M

Float Shares:1.92M

Volume Ratio:1.45

T/O Rate:27.56%

Dividend:1.03

Dividend Rate:0.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

FDA Grants Landmark Approval to Revolutionary Medicines' Pancreatic Cancer Therapy, Projected to Exceed $9 Billion in Sales by 2032

FDA Approves Test to Identify Gastroesophageal Cancer Patients Eligible for Jazz Pharmaceuticals' Ziihera

MT Newswires Live

3 AI Healthcare Stocks Retail Investors Are Watching In Australia

Simply Wall St.

Sector Update: Healthcare

MT Newswires Live

Roche receives FDA approval for companion diagnostic tests for Ziihera

Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)

Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GE Healthcare’s New Spectral CT Study: What Investors Should Watch

Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback

Health Care Roundup: Market Talk

FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease

Boston Scientific announces recall of ENROUTE Transcarotid NPS

Xikang Cloud Hospital Narrows Loss as Policy Tailwinds Support AI-Enabled Healthcare Expansion

NeOnc’s Clinical Story Is Now the Main Event

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

MT Newswires Live

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":295.76,"timestamp":1787947200000,"preClose":331.23,"halted":0,"volume":530479,"hourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"delay":0,"changeRate":-0.10708571083537127,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Not Yet Opened","change":-35.47,"latestTime":"08-28 16:00:00 EDT","open":322.785,"high":323,"low":294.7,"amount":162523074.03118002,"amplitude":0.085439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":331.23,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.003472,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":323.7,"preClose":331.23,"latestTime":"09:29 EDT","volume":2163,"amount":708605.00781,"timestamp":1787923795309,"change":-7.53,"changeRate":-0.022733,"amplitude":0.034055},"postHourTrading":{"tag":"盘后","latestPrice":295.76,"preClose":295.76,"latestTime":"19:55 EDT","volume":2719,"amount":805526.7898,"timestamp":1787961358839,"change":0,"changeRate":0,"amplitude":0.003466},"volumeRatio":1.445542973311124,"impliedVol":0.9101,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.445542973311124,"shares":1924486,"dividePrice":1.0268,"high":323,"amplitude":0.085439,"preClose":331.23,"low":294.7,"week52Low":68,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":295.76,"eps":0,"divideRate":0.003472,"volume":530479,"delay":0,"ttmEps":0,"open":322.785,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":317.2,"twentyDayClose":227.4,"sixtyDayClose":165.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178759120","title":"FDA Grants Landmark Approval to Revolutionary Medicines' Pancreatic Cancer Therapy, Projected to Exceed $9 Billion in Sales by 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1178759120","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178759120?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774418,"startTime":"0","endTime":"0","summary":"In a historic development for oncology, Revolution Medicines (RevMed) has secured US Food and Drug Administration (FDA) approval for its pancreatic cancer drug daraxonrasib, marking the first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741975","title":"FDA Approves Test to Identify Gastroesophageal Cancer Patients Eligible for Jazz Pharmaceuticals' Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741975","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741975?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:52","pubTimestamp":1787773970,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration has approved usage of Roche's diagnostics tests to identify HER2-positive metastatic gastroesophageal adenocarcinoma patients who may be eligible for treatment with Jazz Pharmaceuticals'  Ziihera, Roche said Wednesday.Roche further said that two Ziihera-containing regimens are now FDA approved for the first-line treatment of adults with unresectable locally advanced or metastatic HER2-positive GEA.Shares of Jazz Pharmaceuticals were down 4.3% in Wednesday trading.Price: 250.04, Change: -10.19, Percent Change: -3.92","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LABU","BK4532","BK4588","IE00BN0W2V16.EUR","LU0154245756.USD","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4007","JAZZ","IE00BN0W2W23.USD","BK4533","LU0154245673.USD","IE00BN0W2T93.GBP","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744290","title":"3 AI Healthcare Stocks Retail Investors Are Watching In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744290","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744290?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:26","pubTimestamp":1787772401,"startTime":"0","endTime":"0","summary":"Global healthcare spending from governments remains in focus as China directs more public budget towards healthcare and social security. That kind of policy support can help AI healthcare companies find customers who are under pressure to cut costs and improve care quality at the same time. This article looks at 3 transformative AI healthcare stocks from our screener that aim to benefit from this long term shift.\nThe three stocks below are just a starting sample from this AI healthcare theme,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-ai-healthcare-stocks-retail-investors-are-watching-in-aust-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-ai-healthcare-stocks-retail-investors-are-watching-in-aust-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","VGT","XKO.AU","AGIX","DACE.AU","IISV.AU","XAO.AU","E200.AU","CHAT","GEAR.AU","XBI","VTHR","NOBL","EIGA.AU","BK4581","LU0029874061.USD","AIPO","VAS.AU","XJO.AU","HCSG","IME.AU","QRE.AU","BK4550","BK7094","IIGF.AU","OZR.AU","ARTY","ISBC","SHG.AU","SLF.AU","BK4137","BK4585","IMLC.AU","QTOC","TCAF","AYA.AU","IOZ.AU","LU0128526141.USD","OZF.AU","IXJ","CGCV","ZYAU.AU","XLV","VAP.AU","STW.AU","QFN.AU","BBOZ.AU","GIVE.AU","VHT","BEAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662497867","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662497867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662497867?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:07","pubTimestamp":1787771265,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  down 0.9%.The iShares Biotechnology ETF  decreased 0.5%.In corporate news, Eli Lilly  said Wednesday that a real-world study showed sustained use of its weight-management drug Zepbound was associated with lower healthcare costs among adults older than 55 with overweight or obesity, compared with similar untreated adults. Lilly shares were down 3.3%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443895.HKD","LU1093756168.USD","SG9999014906.USD","IE00BN29S564.USD","SG9999013999.USD","LU2237443549.SGD","LU2456880835.USD","LU1691799644.USD","SG9999018865.SGD","LU2491050154.USD","LU0889565916.HKD","IE00B1XK9C88.USD","FTXH","LU1988902786.USD","LU2023250504.SGD","LU2491050071.SGD","CURE","WDNA","LU0882574139.USD","LU2168564222.USD","LU2471134796.USD","LU2750360997.AUD","RXL","LU0061475181.USD","LU2746668974.SGD","LU2361045086.USD","SG9999001176.SGD","LU0689472784.USD","LU2896262040.SGD","IE00BK4W5M84.HKD","LU0210536198.USD","LU0256863902.USD","SG9999018857.SGD","LU1917777945.USD","LU1291159041.SGD","LU0006306889.USD","LU0353189763.USD","LU0432979614.USD","LU1366192091.USD","IE00B4JS1V06.HKD","LU1623119135.USD","IE0009355771.USD","LU0640476718.USD","LU1868836914.USD","LU2471134952.CNY","TRUH","IE00B4R5TH58.HKD","LU0094547139.USD","LU2756315664.SGD","LU0096364046.USD","LU2106854487.HKD","LU2089984988.USD","SG9999015986.USD","LU1145028129.USD","LU0820562030.AUD","LU0823416689.USD","LU0823434740.USD","LU2089283258.USD","LLY","LU0471298694.HKD","LU1868837300.USD","LU2089284900.SGD","LU2168563687.JPY","SG9999017495.SGD","SGXZ99366536.SGD","TMED","BK4581","LU0345770993.USD","LU2023251221.USD","LU0820561909.HKD","LU1989771016.USD","LU2111349929.HKD","SG9999014898.SGD","IE0004445239.USD","MHIP","LU1064131342.USD","LU2360106947.USD","LU2552382058.USD","SG9999014880.SGD","IHE","IE00BJJMRZ35.SGD","LU0256863811.USD","LU0417517546.SGD","LU2491049909.HKD","LU1280957306.USD","LU0820561818.USD","IE00BFSS7M15.SGD","LU0234572021.USD","VHT","LU0964807845.USD","IE00BWXC8680.SGD","BK4534","LU2108987350.USD","LU0943347566.SGD","LU2471134523.USD","LU2361044949.HKD","OZEM","IE00BFTCPJ56.SGD","BK4516","IE00BKDWB100.SGD","LU1093756325.SGD","LU1232071149.USD","BK4588","LU1323610961.USD","PPH","IE00BKPKM429.USD","IE00B7KXQ091.USD","LU0225283273.USD","LU2168564495.EUR","LU2462157665.USD","SGXZ57979304.SGD","SG9999014914.USD","LU0289739699.SGD","LU0266013472.USD","LU1720051108.HKD","LU2028103732.USD","LU2211815571.USD","LU2417539215.USD","LU0316494557.USD","LU1979441026.SGD","IE00BJJMRX11.SGD","LABU","JDOC","CANC","FHLC","LU0323591593.USD","LU2023250330.USD","SGXZ81514606.USD","LU0114720955.EUR","IBB","GB00BDT5M118.USD","LLYZ","ELIS","LU0109394709.USD","LU0345770308.USD","PJP","LLYX","LU1267930730.SGD","LU1814569148.SGD","LU2602419157.SGD","THNR","LU0354030438.USD","LU0320765992.SGD","IXJ","IE0002141913.USD","LU1868836591.USD","LU0158827781.USD","LU1127390331.HKD","LU2750360641.GBP","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU0079474960.USD","LU2265009873.SGD","ELIL","LU0106261372.USD","LLII","LU0786609619.USD","LU0320765059.SGD","LU2471134879.HKD","LU1061106388.HKD","LU1804176565.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU2087625088.SGD","LU0787776722.HKD","LU0882574055.USD","XBI","LU2237443978.SGD","LU1057294990.SGD","SGXZ51526630.SGD","LU0097036916.USD","LU2552382132.HKD","IE00BJT1NW94.SGD","LU2357305700.SGD","XLV","LU0122379950.USD","LU1551013342.USD","MEDX","LU2063271972.USD","LU0174119429.USD","LU2461242641.AUD","LU2324357040.USD","IE00BK4W5L77.USD","SG9999015945.SGD","LU2361044865.SGD","ILDR","SG9999015978.USD","MEDI","IE00BJJMRY28.SGD","LU2237443465.HKD","LU1023059063.AUD","LU2264538146.SGD","IE00BJLML261.HKD","LU0683600562.USD","LU1974910355.USD","BK4533","HRTS","LU1868836757.USD","LU2746668461.USD","IE0001KFT4U8.USD","LU0456855351.SGD","LU0471298777.SGD","BK4007","LU0672654240.SGD","LU1548497426.USD","LU1551013425.SGD","LU2552382215.SGD","LU0203201768.USD","LU2237438978.USD","IE0004445015.USD","LU0203202063.USD","LU2468319806.SGD","LU0238689110.USD","LU0466842654.USD","LU2756315318.SGD","LU0158827948.USD","LU2168564149.EUR","BK4599","LU2168564065.EUR","LU0385154629.USD","LU2237443622.USD","LU2237443382.USD","LU1035775433.USD","LU1720051017.SGD","LU2236285917.USD","SG9999001176.USD","LU2271345857.HKD","GDOC","SG9999015952.SGD","BK4585","LU0823434583.USD","LU1629891620.HKD","IE0005OL40V9.USD","LU1868837136.USD","SGXZ31699556.SGD","AGNG","LU0354030511.USD","LU0058720904.USD","LU0353189680.USD","LU2112291526.USD","LU1983299246.USD","IE00B1BXHZ80.USD","IYH","LU1069344957.HKD","IE00B775H168.HKD","LU2462591350.SGD","LU0133085943.USD","LU2213496289.HKD","LU0198837287.USD","LU0109391861.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BK4007","TECB","GNMX","RHHBY","PINK","GDOC","IBB","FRTY","MRNX","IEIH","NVIB","BMED","MRNY","BK4585","BK4588","CANC","IYH","XLVX","BBP","LABU","IDNA","MEDI","RSPH","SYNB","HRTS","PSCH","TBXU","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749608","title":"Analysts’ Top Healthcare Picks: CVS Health (CVS), TuHURA Biosciences (HURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749608?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:20","pubTimestamp":1787768419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS) and TuHURA Biosciences (HURA) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-cvs-health-cvs-tuhura-biosciences-hura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0162691827.USD","LU1983299246.USD","BK4588","IE00B19Z3B42.SGD","HURA","LU0070302665.USD","IE00B7SZLL34.SGD","BK4196","XBI","LU0320765489.SGD","LU0432979614.USD","BK4504","LU2357627491.SGD","LU1699723380.USD","LU2125909593.SGD","LU1236620834.HKD","LU0072461881.USD","LU0128526141.USD","IE00BZ1G4Q59.USD","LU0211331839.USD","BK4581","IE00BKVL7J92.USD","LU1059921491.USD","LU2125909247.SGD","LU0061475181.USD","IE0002270589.USD","LU0029874061.USD","LU1923622614.USD","IHF","CVS","LU1236620750.USD","LU0006061336.USD","LU1571399168.USD","IE00BSNM7G36.USD","RTH","XLV","BK4139","LABU","LU2433249047.HKD","LU0208291251.USD","IE00B19Z3581.USD","LU0859254822.USD","BK4585","BK4550","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662493367","title":"Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662493367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662493367?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:05","pubTimestamp":1787767521,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/botanix-pharm-strong-sofdra-adoption-and-margin-upside-support-buy-rating-with-unchanged-1-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/botanix-pharm-strong-sofdra-adoption-and-margin-upside-support-buy-rating-with-unchanged-1-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4581","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662498417","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662498417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662498417?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:00","pubTimestamp":1787767225,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN). Gossamer Bio (GOSS)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-gossamer-bio-goss-and-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-gossamer-bio-goss-and-biohaven-ltd-bhvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4505","BK4588","LU0029874061.USD","HCSG","XBI","BK4139","BK4137","LU0128526141.USD","LU1093756168.USD","XLV","LU1093756325.SGD","GOSS","BHVN","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","BK4585","RVMD","IE00B4R5TH58.HKD","MEDI","MRNY","BBH","IE00BJT1NW94.SGD","LU0320765992.SGD","MRNX","NVIB","IE0002141913.USD","IDNA","PTH","LU0109394709.USD","BBP","PSCH","LFSC","TBXU","BK4139","IE00BJJMRZ35.SGD","XLVX","BMED","CANC","IE00B2B36J28.USD","RSPH","GNMX","TECB","IEIH","SYNB","GDOC","IBB","IE0009354923.USD","IE00BFTCPJ56.SGD","IYH","FRTY","IE0009355771.USD","LABU","BK4588","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","XLVX","IE0009355771.USD","LABU","GDOC","LU0889565916.HKD","FRTY","IYH","CANC","BK4588","GNMX","SYNB","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","IEIH","BBH","LFSC","IE00B2B36J28.USD","MEDI","TBXU","TECB","MRNX","PSCH","BK4139","BBP","MRNY","IE0002141913.USD","PINK","IDNA","IE0009354923.USD","RSPH","NVIB","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BMED","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759746","title":"U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759746","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:59","pubTimestamp":1787763540,"startTime":"0","endTime":"0","summary":"RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351615/0/en/u-s-fda-approves-revolution-medicines-rasonque-daraxonrasib-the-first-broad-ras-targeted-medicine-in-metastatic-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1978683503.SGD","BK4141","LU2360107325.USD","TTDU","LU1861220033.SGD","LU1720051108.HKD","BK4605","BK4009","BK4023","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LABU","LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","LU1861219969.SGD","ONX","IE00BZ199S13.USD","ITT","IE00B4R5TH58.HKD","IE0009355771.USD","LU0053671581.USD","PTH","BBH","CANC","ON","LU0724618433.USD","LU1854103824.USD","BK4585","LU0210528500.USD","EMA","IE0009354923.USD","BK4225","RVMD","BK4139","TTD","BK4613","PFS","BK4588","SRET","ONG","LU0124384867.USD","BK4512","IDNA","L","LU2487616109.SGD","IE00BD6J9T35.USD","LU0109394709.USD","HR","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745119","title":"GE Healthcare’s New Spectral CT Study: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745119?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:31","pubTimestamp":1787761872,"startTime":"0","endTime":"0","summary":"Ge Healthcare Technologies Inc. ($GEHC) announced an update on their ongoing clinical study. GE Healthcare is running a new study called “Data Coll...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ge-healthcares-new-spectral-ct-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ge-healthcares-new-spectral-ct-study-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0353189763.USD","LU1366333091.USD","LU0029874061.USD","LU0354030438.USD","GE","BK4585","BK4211","LU2087625088.SGD","BK4206","LU1066051811.HKD","LU2543165471.USD","LU2756315318.SGD","LU0689472784.USD","LU2168564495.EUR","LU1988902786.USD","LU0077335932.USD","LU1261432733.SGD","XLV","LU0820562030.AUD","LU2168564222.USD","LU1066051225.USD","TRUI","LU0354030511.USD","UXI","ISBC","DFEN","HCSG","LU0128526141.USD","LU0943347566.SGD","BK4581","LU1551013425.SGD","NATO","XBI","BK4588","LU0820561909.HKD","LU1064131342.USD","LU0267386448.USD","BK4501","LU2756315664.SGD","LU1093756168.USD","XAR","BK4137","ITA","EXI","MISL","LU1119994496.HKD","PPA","LABU","LU0868494617.USD","LU0157215616.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662126745","title":"Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2662126745","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662126745?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:22","pubTimestamp":1787761343,"startTime":"0","endTime":"0","summary":"The latest update is out from Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ). Worldwide Healthcare Trust PLC has executed a market purchase of 40...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","BK4585","LABU","HCSG","BK4588","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662455057","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2662455057","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662455057?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:20","pubTimestamp":1787761200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0343 ET - WuXi XDC Cayman retains its bull at Citi Research on s","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748785","title":"FDA Approves Drug for Pancreatic Cancer in Incredible Moment for Deadly Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748785?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:18","pubTimestamp":1787757480,"startTime":"0","endTime":"0","summary":"For four decades, cancer researchers fought to disable a stubborn mutation that made pancreatic cancer a death sentence-to little avail.Now, doctors have a medicine that targets the mutation. The Food","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK6027","RVMD","BBH","RDR.SI","IE0009355771.USD","IE0002141913.USD","BK4588","IE0009354923.USD","BK6515","PTH","LU0109394709.USD","BK4139","CANC","IDNA","IE00BFTCPJ56.SGD","LABU","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748714","title":"Boston Scientific announces recall of ENROUTE Transcarotid NPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748714","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748714?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:00","pubTimestamp":1787756412,"startTime":"0","endTime":"0","summary":"The FDA is aware that Boston Scientific (BSX) has issued a letter to affected customers recommending certain Percutaneous Catheter be removed from ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/boston-scientific-announces-recall-of-enroute-transcarotid-nps-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/boston-scientific-announces-recall-of-enroute-transcarotid-nps-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2087625088.SGD","LU1291159041.SGD","LU1023059063.AUD","LU1720051017.SGD","LU0267386448.USD","LU0187121727.USD","LU0048584097.USD","LABU","BK4585","LU0432979614.USD","LU0138981039.USD","LU2265009873.SGD","LU2491050154.USD","LU1804176565.USD","LU2506952170.USD","LU2362541513.USD","SGXZ57979304.SGD","BK4581","LU0251132253.USD","LU1791710582.SGD","LU2324357040.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU2506951958.HKD","LU0353189680.USD","LU1989764748.USD","LU0266013472.USD","BK4082","BSX","LU1061106388.HKD","LU1989771016.USD","LU1989772923.USD","LU2362541273.HKD","LU0823417653.USD","LU1718418525.SGD","LU1720051108.HKD","LU2244417387.USD","LU1153585028.USD","SG9999001176.USD","LU0114720955.EUR","IE0009355771.USD","LU1057294990.SGD","LU1989772840.SGD","IE00B2B36J28.USD","LU2242649171.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","SG9999013999.USD","LU0011850046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662171081","title":"Xikang Cloud Hospital Narrows Loss as Policy Tailwinds Support AI-Enabled Healthcare Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662171081","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662171081?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:13","pubTimestamp":1787753608,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NEUSOFT XIKANG HOLDINGS INC. ( ($HK:9686) ). Xikang Cloud Hospital Holdings reported interim revenue of RMB182....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xikang-cloud-hospital-narrows-loss-as-policy-tailwinds-support-ai-enabled-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xikang-cloud-hospital-narrows-loss-as-policy-tailwinds-support-ai-enabled-healthcare-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CHAT","BK4581","AGIX","AIPO","XBI","ARTY","BK4585","LABU","LU0029874061.USD","QTOC","BK4588","VTHR","HCSG","XLV","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175127","title":"NeOnc’s Clinical Story Is Now the Main Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175127?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:39","pubTimestamp":1787751540,"startTime":"0","endTime":"0","summary":"DENVER, Aug.  26, 2026  -- NeOnc Technologies Holdings  has reached a point where the market conversation can move toward a much more consequential question: What happens if NEO100’s clinical results translate into a viable regulatory pathway for a difficult-to-treat form of brain cancer?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351481/0/en/neonc-s-clinical-story-is-now-the-main-event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662712851","title":"Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662712851","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662712851?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:18","pubTimestamp":1787750291,"startTime":"0","endTime":"0","summary":"Healthcare stocks were leaning lower pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF  down 0.1% and the iShares Biotechnology ETF  declining by 0.5%.Boston Scientific  has identified a cybersecurity incident that affected its certain IT systems and led to global disruption in operations, the company said in a filing. Boston Scientific shares were down more than 5% premarket.Jazz Pharmaceuticals'  wholly owned subsidiary plans to offer $1 billion of exchangeable senior notes due 2032, the company said. Jazz Pharmaceuticals stock was down more than 2% pre-bell.Summit Therapeutics  partner Akeso reported \"positive\" results from a phase 3 trial of ivonescimab plus chemotherapy, compared with durvalumab plus chemotherapy as a first-line treatment of advanced biliary tract cancer. Shares of Summit Therapeutics were up more than 12% premarket.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541273.HKD","BSX","LU0128526141.USD","IBB","IE0002141913.USD","SMMT","LU1023059063.AUD","LU2357305700.SGD","LU0225283273.USD","LU0011850046.USD","LU0114720955.EUR","LU2244417387.USD","HCSG","LU2362541513.USD","LU0266013472.USD","LU1061106388.HKD","JAZZ","BSX.AU","LU2488822045.USD","BK7095","LU0345769631.USD","LU2506951875.HKD","IE00BN0W2T93.GBP","SGXZ57979304.SGD","LU1153585028.USD","BK4082","LU1989764664.SGD","LU1791710400.SGD","XLV","LU2491050154.USD","BK4581","IE00B4R5TH58.HKD","LU0077335932.USD","IE0009355771.USD","LU0238689110.USD","LU1989772923.USD","LU0950375773.USD","LU0029874061.USD","LABU","XBI","LU1989771016.USD","LU0187121727.USD","LU0109394709.USD","BK4504","IE00BN0W2W23.USD","LU1291159041.SGD","LU0823416689.USD","LU0528227936.USD","LU2491049909.HKD","LU0823417653.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662126847","title":"Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662126847","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662126847?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:15","pubTimestamp":1787750100,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Aug.  26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minim","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351428/0/en/inspire-medical-systems-inc-to-present-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0256863811.USD","LU0162691827.USD","LU1668664300.SGD","LU2065731478.USD","LU0971096721.USD","LU0128526141.USD","TFNS","LU1267930227.SGD","PGF","XBI","LU2461242641.AUD","LU0942090050.USD","LU0417517546.SGD","LU0130102774.USD","LU0128525929.USD","LU0314106906.USD","LU1074936037.SGD","BK4582","LU0868494708.USD","INSP","XLV","LABU","LU0683600562.USD","LU0742534661.SGD","LU0130517989.USD","LU1894683264.USD","BK4167","LU0128525689.USD","BK4559","LU1267930573.SGD","LU0708994859.HKD","LU0154236417.USD","LU1506573853.SGD","LU1814569148.SGD","LU1363072403.SGD","BK4588","IE00B19Z3581.USD","LU0175139822.USD","LU0310800379.SGD","IYF","HCSG","KBWB","LU0320765489.SGD","FTXO","LU0868494617.USD","LU1894683348.USD","LU2361045086.USD","LU0211327993.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":6,"totalSize":404,"code":"91000000","status":"200"}]}}